Science and Discovery

Virtual Biotech

1 article

Editorial illustration for Inside Stanford's Virtual Biotech: 37,000 AI Agents and the Three Discovery Tasks They Performed
Health & Medicine

Inside Stanford's Virtual Biotech: 37,000 AI Agents and the Three Discovery Tasks They Performed

Stanford Medicine researchers have developed a "virtual biotech" company composed of 37,000 AI agents, demonstrating its capability to perform three critical early-stage drug discovery tasks: target prioritization, cancer target validation, and analysis of failed clinical trials.

Marcus Cole·October 27, 2026